206 related articles for article (PubMed ID: 29790240)
1. Understanding mucosal and microbial functionality of the female reproductive tract by metaproteomics: Implications for HIV transmission.
Berard AR; Perner M; Mutch S; Farr Zuend C; McQueen P; Burgener AD
Am J Reprod Immunol; 2018 Aug; 80(2):e12977. PubMed ID: 29790240
[TBL] [Abstract][Full Text] [Related]
2. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
Vitali D; Wessels JM; Kaushic C
AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
[TBL] [Abstract][Full Text] [Related]
3. Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition.
Noël-Romas L; Perner M; Molatlhegi R; Farr Zuend C; Mabhula A; Hoger S; Lamont A; Birse K; Berard A; McCorrister S; Westmacott G; Leslie A; Poliquin V; Heffron R; McKinnon LR; Burgener AD
PLoS Pathog; 2020 Dec; 16(12):e1009097. PubMed ID: 33362285
[TBL] [Abstract][Full Text] [Related]
4. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
[TBL] [Abstract][Full Text] [Related]
5. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis.
Burgener A; McGowan I; Klatt NR
Curr Opin Immunol; 2015 Oct; 36():22-30. PubMed ID: 26151777
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications.
Yarbrough VL; Winkle S; Herbst-Kralovetz MM
Hum Reprod Update; 2015; 21(3):353-77. PubMed ID: 25547201
[TBL] [Abstract][Full Text] [Related]
7. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
Wessels JM; Felker AM; Dupont HA; Kaushic C
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
[TBL] [Abstract][Full Text] [Related]
8. Bacterial vaginosis and the cervicovaginal immune response.
Mitchell C; Marrazzo J
Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
[TBL] [Abstract][Full Text] [Related]
9. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection.
Choi MW; Isidoro CA; Gillgrass A
Curr Opin Virol; 2024 Jun; 66():101398. PubMed ID: 38484474
[TBL] [Abstract][Full Text] [Related]
11. Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.
Jewanraj J; Ngcapu S; Liebenberg LJP
Am J Reprod Immunol; 2021 Nov; 86(5):e13478. PubMed ID: 34077596
[TBL] [Abstract][Full Text] [Related]
12. The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
McKinnon LR; Achilles SL; Bradshaw CS; Burgener A; Crucitti T; Fredricks DN; Jaspan HB; Kaul R; Kaushic C; Klatt N; Kwon DS; Marrazzo JM; Masson L; McClelland RS; Ravel J; van de Wijgert JHHM; Vodstrcil LA; Tachedjian G
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):219-228. PubMed ID: 30638028
[TBL] [Abstract][Full Text] [Related]
13. Influence of common mucosal co-factors on HIV infection in the female genital tract.
Ferreira VH; Kafka JK; Kaushic C
Am J Reprod Immunol; 2014 Jun; 71(6):543-54. PubMed ID: 24617528
[TBL] [Abstract][Full Text] [Related]
14. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
15. Role of semen in modulating the female genital tract microenvironment--implications for HIV transmission.
Doncel GF; Anderson S; Zalenskaya I
Am J Reprod Immunol; 2014 Jun; 71(6):564-74. PubMed ID: 24702729
[TBL] [Abstract][Full Text] [Related]
16. Research gaps in defining the biological link between HIV risk and hormonal contraception.
Murphy K; Irvin SC; Herold BC
Am J Reprod Immunol; 2014 Aug; 72(2):228-35. PubMed ID: 24548147
[TBL] [Abstract][Full Text] [Related]
17. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier.
Borgdorff H; Gautam R; Armstrong SD; Xia D; Ndayisaba GF; van Teijlingen NH; Geijtenbeek TB; Wastling JM; van de Wijgert JH
Mucosal Immunol; 2016 May; 9(3):621-33. PubMed ID: 26349657
[TBL] [Abstract][Full Text] [Related]
18. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.
Kaul R; Trabattoni D; Bwayo JJ; Arienti D; Zagliani A; Mwangi FM; Kariuki C; Ngugi EN; MacDonald KS; Ball TB; Clerici M; Plummer FA
AIDS; 1999 Jan; 13(1):23-9. PubMed ID: 10207541
[TBL] [Abstract][Full Text] [Related]
19. Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus.
Farr Zuend C; Lamont A; Noel-Romas L; Knodel S; Birse K; Kratzer K; McQueen P; Perner M; Ayele H; Mutch S; Berard AR; Schellenberg JJ; Senturk F; McCorrister S; Westmacott G; Mulhall F; Sandberg B; Yu A; Burnett M; Poliquin V; Burgener AD
Microbiome; 2023 Jul; 11(1):159. PubMed ID: 37491398
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.
Venkatesh KK; Cu-Uvin S
Am J Reprod Immunol; 2014 Jun; 71(6):495-504. PubMed ID: 24832617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
